Robert M Weinrieb, MD, FACLP

Professor of Psychiatry at the University of Pennsylvania Perelman School of Medicine and Philadelphia Veterans Affairs Medical CenterDr. Weinrieb came to Philadelphia in 1991 after completing his residency in adult psychiatry at St. Vincent's Hospital of NY Medical College in Greenwich Village, NY. He then completed a Department of Veteran's Affairs Fellowship in Addiction Medicine from the Penn/VA Center for the Study of Addictions in 1993. His responsibilities included having served as Medical Director of the Treatment Research Center for 7 years as well as serving on the Penn Institutional Review Board for Human Studies, the Penn Medical School Student Standards Committee and the Standing Conflict of Interest Committee of the University of Pennsylvania. From his work as the consultant psychiatrist for the liver transplant team of the Hospital of the University of Pennsylvania which he began in 1995, Dr. Weinrieb became an NIH and VAMC grant funded investigator focusing his interests on the treatment of psychiatric and addictive disorders in solid organ transplant patients. His primary clinical and research interests focus on liver transplantation for people with Alcohol Use Disorders. Dr. Weinrieb has been the recipient of a number of research and teaching awards, including the Lindback Award for Distinguished Teaching from the University of Pennsylvania. He was the Director of Consultation-Liaison Psychiatry and the Psychiatric Emergency Evaluation Center at the Hospital of the University of Pennsylvania from 2006-2016 and is currently Chief Psychiatric Consultant for the Penn Transplant Institute and Program Director of an ACGME accredited Fellowship in Consultation-Liaison Psychiatry at the Hospital of the University of Pennsylvania/Penn VAMC, Perelman School of Medicine. Dr. Weinrieb founded and directs the first longitudinal outpatient psychiatric clinic for transplant patients in the United States. Together with his transplant psychiatry and hepatology colleagues, he started one of the first alcohol treatment programs designed exclusively for high-risk liver transplant patients with AUDs in the USA in addition to partnering with Penn hepatologists in a co-located hepatology and psychiatry clinic focusing on high-risk liver transplant patients with AUDs. He thoroughly enjoys teaching and mentoring undergraduates, medical and dental students, advanced practice nursing students, psychiatry and neurology residents.